Medirom MOTHER Labs Raises ¥9 Billion in Series A Funding
MEDIROM MOTHER Labs Co., Ltd. has raised ¥9 billion in a Series A funding round through a private placement of new shares. The investment was made by internal investors, including President and CEO Yoshio Uekusa and Director Ryo Saito. The funds will be used to enhance the development of the MOTHER Bracelet wearable device and to support the launch of new healthcare products.
MEDIROM MOTHER Labs Co., Ltd., a subsidiary of Medirom Healthcare Technologies Inc., has completed a private placement of new shares as part of a ¥9 billion Series A round. The investment was made by internal investors, including the company’s President and CEO, Yoshio Uekusa, and Director, Ryo Saito. The capital increase will be used to accelerate development of the MOTHER Bracelet wearable device and support the launch of new healthcare products. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-104378), on October 30, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
